Akero Therapeutics 3Q Loss/Shr 71c >AKRO

Health Care Up on Obesity-Drug Optimism -- Health Care Roundup

Why Akero Therapeutics Lost More Than Half Its Value And Dragged Down 89bio

Akero Therapeutics shares plunge on liver disease treatment's mixed results

Akero Shares Slide 68% on Study Miss; 89bio Shares Feel Fallout

Akero Therapeutics Shares Plummet Premarket After NASH Study Update

Akero Therapeutics Shares Jump 19% on Upcoming Disclosure of Study Results to Treat Cirrhosis

Akero Therapeutics 2Q Loss $31.1M >AKRO

Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Obesity Drugs Won’t Starve These Other Potential Blockbusters

Weight-loss drugs in development aim to replace injections with pills

Akero Therapeutics 1Q Loss/Shr 55c >AKRO

Top 1% Biotech 89bio Scores 25% Gain As Battle In Liver Disease Heats Up

Akero Therapeutics 4Q Loss/Shr 49c >AKRO

Purple Innovation and Edgewise Therapeutics See Activist Investor Action